Medi Assist Healthcare Services Limited announced on May 9, 2026, that its Board of Directors has recommended a final dividend of ₹2 per equity share for the financial year ended March 2026. The announcement was made to the National Stock Exchange post market hours, alongside a separate disclosure regarding the identification of additional Senior Managerial Personnel at the company.
Dividend Details and Yield
The declared dividend of ₹2 per equity share translates to a dividend yield of approximately 0.53% at the current market price of ₹376. This payout represents a face value consideration for shareholders on the record date, which is yet to be formally announced. At a market capitalisation of ₹2,808.79 Cr, the total dividend outgo for the company will be calculated based on the total number of equity shares outstanding.
Year-on-Year Comparison and Dividend Trend
The FY26 dividend marks a 50% reduction compared to the ₹4 per equity share final dividend that the Board had recommended on May 15, 2024, for FY24. The available two-year dividend history reflects the following trend:
- FY24: ₹4 per equity share (recommended May 15, 2024)
- FY26: ₹2 per equity share (recommended May 9, 2026)
The halving of the per-share payout is a notable shift in capital return policy and will be a key data point for income-focused investors tracking the company's shareholder returns over successive cycles.
Valuation Context: PE vs Sector PE
Medi Assist is currently trading at a price-to-earnings ratio of 49.96, marginally below the sector PE of 50.2. This near-parity with the sector multiple suggests the stock is trading broadly in line with its healthcare peers on an earnings basis. However, the declining dividend payout may prompt investors to reassess the earnings-to-distribution ratio more closely in the context of the company's reinvestment priorities.
52-Week Range and Current Price Context
The stock closed at ₹376 on May 9, 2026, down ₹1.65 or 0.44% for the session. The 52-week high of ₹594.10 was recorded on August 12, 2025, while the 52-week low of ₹293 was touched on March 30, 2026. At the current price, the stock is trading approximately 36.7% below its 52-week peak and around 28.3% above its 52-week trough, indicating that the stock has partially recovered from its recent lows but remains well off its highs.
Delivery Data and Market Activity
Trading volumes on May 9 stood at 1,53,883 shares, with a delivery percentage of 51.52%. A delivery ratio above 50% generally indicates that a meaningful proportion of buyers intend to hold their positions rather than square off intraday, reflecting some degree of conviction-based participation on the day of the board meeting. Daily volatility is recorded at 2.54%, suggesting moderate price fluctuation in recent sessions.
Management Disclosure
Separately, the company also informed the exchange about the identification of additional Senior Managerial Personnel, a regulatory disclosure requirement under applicable SEBI listing obligations. No further details on the specific roles or names were included in the exchange filing.
Investors tracking Medi Assist should note the combination of a reduced dividend payout, a stock price significantly below its 52-week high, and a PE ratio closely aligned with sector peers when evaluating the company's current positioning within the listed healthcare services segment.
